Townsquare Capital LLC Boosts Position in Johnson & Johnson (NYSE:JNJ)

Townsquare Capital LLC grew its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 6.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 132,329 shares of the company's stock after acquiring an additional 8,517 shares during the period. Townsquare Capital LLC's holdings in Johnson & Johnson were worth $19,137,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Norges Bank acquired a new stake in Johnson & Johnson during the 4th quarter valued at approximately $4,390,037,000. Raymond James Financial Inc. acquired a new stake in shares of Johnson & Johnson during the fourth quarter worth $1,339,878,000. Vanguard Group Inc. grew its holdings in Johnson & Johnson by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 232,792,559 shares of the company's stock worth $33,666,460,000 after acquiring an additional 1,772,706 shares during the period. Franklin Resources Inc. boosted its position in shares of Johnson & Johnson by 11.4% during the 3rd quarter. Franklin Resources Inc. now owns 16,840,069 shares of the company's stock valued at $2,721,355,000 after purchasing an additional 1,729,281 shares in the last quarter. Finally, Amundi increased its stake in shares of Johnson & Johnson by 16.2% in the 4th quarter. Amundi now owns 11,930,183 shares of the company's stock valued at $1,698,984,000 after acquiring an additional 1,660,458 shares in the last quarter. 69.55% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, VP Robert J. Decker sold 6,999 shares of the stock in a transaction that occurred on Tuesday, February 25th. The shares were sold at an average price of $165.88, for a total transaction of $1,160,994.12. Following the sale, the vice president now owns 21,001 shares in the company, valued at $3,483,645.88. This represents a 25.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Timothy Schmid sold 403 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $156.15, for a total transaction of $62,928.45. Following the completion of the transaction, the executive vice president now owns 15,098 shares of the company's stock, valued at approximately $2,357,552.70. The trade was a 2.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.16% of the stock is currently owned by company insiders.

Remove Ads

Johnson & Johnson Trading Down 0.5 %

Shares of Johnson & Johnson stock traded down $0.71 on Tuesday, hitting $153.66. The stock had a trading volume of 10,721,577 shares, compared to its average volume of 7,975,065. The stock's 50-day simple moving average is $159.38 and its two-hundred day simple moving average is $155.11. The stock has a market cap of $370.29 billion, a price-to-earnings ratio of 23.11, a PEG ratio of 2.56 and a beta of 0.49. The company has a quick ratio of 0.86, a current ratio of 1.11 and a debt-to-equity ratio of 0.43. Johnson & Johnson has a one year low of $140.68 and a one year high of $169.99.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last posted its earnings results on Tuesday, April 15th. The company reported $2.77 earnings per share for the quarter, topping analysts' consensus estimates of $2.59 by $0.18. The firm had revenue of $21.89 billion for the quarter, compared to the consensus estimate of $21.65 billion. Johnson & Johnson had a return on equity of 34.24% and a net margin of 18.20%. As a group, sell-side analysts predict that Johnson & Johnson will post 10.58 EPS for the current year.

Johnson & Johnson Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Shareholders of record on Tuesday, May 27th will be paid a dividend of $1.30 per share. This is an increase from Johnson & Johnson's previous quarterly dividend of $1.24. This represents a $5.20 dividend on an annualized basis and a dividend yield of 3.38%. Johnson & Johnson's dividend payout ratio (DPR) is currently 74.59%.

Analyst Ratings Changes

JNJ has been the topic of several recent research reports. Guggenheim reiterated a "neutral" rating on shares of Johnson & Johnson in a report on Wednesday, April 2nd. Raymond James decreased their price target on shares of Johnson & Johnson from $165.00 to $162.00 and set an "outperform" rating for the company in a research note on Monday. Stifel Nicolaus dropped their price objective on shares of Johnson & Johnson from $170.00 to $155.00 and set a "hold" rating on the stock in a research note on Thursday, January 23rd. Argus upgraded Johnson & Johnson to a "strong-buy" rating in a research note on Friday, January 24th. Finally, Morgan Stanley raised their target price on Johnson & Johnson from $163.00 to $164.00 and gave the company an "equal weight" rating in a report on Wednesday, April 9th. Eight analysts have rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Johnson & Johnson presently has a consensus rating of "Moderate Buy" and a consensus target price of $171.50.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.